
LENSAR, Inc. Common Stock
LNSR Real Time Price USDRecent trades of LNSR by members of U.S. Congress
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes in LNSR holdings by institutional investors
Quarterly net insider trading by LNSR's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
LNSR Estimated quarterly lobbying spending
LNSR Revenue by Segment or Geography
New LNSR patent grants
-
Patent Title: Laser methods and systems for addressing conditions of the lens Mar. 18, 2025
-
Patent Title: Second pass femtosecond laser for incomplete laser full or partial thickness corneal incisions Mar. 04, 2025
-
Patent Title: Iris registration method and system Aug. 27, 2024
-
Patent Title: Display screen with graphical user interface for a laser-phacoemulsification system Jul. 23, 2024
-
Patent Title: Display screen with graphical user interface for a laser-phacoemulsification system Jul. 23, 2024
-
Patent Title: System and method of illumination of structures within an eye Jun. 11, 2024
-
Patent Title: System and method for measuring tilt in the crystalline lens for laser phaco fragmentation May. 28, 2024
-
Patent Title: Systems and methods for combined femto-phaco surgery Mar. 26, 2024
-
Patent Title: Methods and systems to provide excluded defined zones for increasing accommodative amplitude Nov. 07, 2023
-
Patent Title: Second pass femtosecond laser for incomplete laser full or partial thickness corneal incisions Sep. 19, 2023
-
Patent Title: Cloud based system cataract treatment database and algorithm system Sep. 12, 2023
-
Patent Title: Laser system and method for correction of induced astigmatism Aug. 08, 2023
-
Patent Title: System for treating the human lens with a laser Jun. 13, 2023
-
Patent Title: Laser methods and systems for addressing, mitigating and reversing presbyopia Mar. 21, 2023
-
Patent Title: Patient interface device for ophthalmic laser procedures Feb. 21, 2023
-
Patent Title: Laser system for eye surgery Feb. 07, 2023
-
Patent Title: Display screen with graphical user interface for a laser-phacoemulsification system Jan. 10, 2023
-
Patent Title: Display screen with graphical user interface for a laser-phacoemulsification system Jan. 10, 2023
-
Patent Title: Display screen with graphical user interface for a laser-phacoemulsification system Jan. 10, 2023
-
Patent Title: Display screen with graphical user interface for a laser-phacoemulsification system Jan. 10, 2023
-
Patent Title: Systems and methods for combined femto-phaco cataract surgery Jan. 03, 2023
-
Patent Title: System and method for laser generated corneal and crystalline lens incisions using a variable f/# optical system with aspheric contact interface to the cornea or rotating and adaptive optics Apr. 26, 2022
-
Patent Title: System and apparatus for treating the lens of an eye Mar. 15, 2022
-
Patent Title: High purity polysilocarb materials, applications and processes Mar. 08, 2022
-
Patent Title: Laser system and method for astigmatic corrections in association with cataract treatment Jan. 18, 2022
-
Patent Title: System and method for measuring tilt in the crystalline lens for laser phaco fragmentation Nov. 30, 2021
-
Patent Title: System and apparatus for delivering a laser beam to the lens of an eye Nov. 09, 2021
-
Patent Title: Combined laser and phacoemulsification system for eye surgery Oct. 19, 2021
-
Patent Title: Iris registration method and system Aug. 17, 2021
-
Patent Title: System and method for measuring and correcting astigmatism using laser generated corneal incisions Aug. 17, 2021
-
Patent Title: System and method for measuring and correcting astigmatism using laser generated corneal incisions Aug. 03, 2021
-
Patent Title: System and method of illumination of structures within an eye Jun. 01, 2021
-
Patent Title: System and method for treating the structure of the human lens with a laser Nov. 24, 2020
-
Patent Title: System and method for measuring tilt Sep. 15, 2020
-
Patent Title: Laser methods and systems for addressing conditions of the lens Jul. 14, 2020
-
Patent Title: System and method for laser generated corneal and crystalline lens incisions using a variable f/# optical system with aspheric contact interface to the cornea or rotating and adaptive optics Jun. 16, 2020
-
Patent Title: System and method for improving the accomodative amplitude and increasing the refractive power of the human lens with a laser Jun. 02, 2020
-
Patent Title: Second pass femtosecond laser for incomplete laser full or partial thickness corneal incisions Dec. 03, 2019
-
Patent Title: System and method for correcting astigmatism using multiple paired arcuate laser generated corneal incisions Nov. 05, 2019
-
Patent Title: Methods and systems to provide excluded defined zones for increasing accommodative amplitude Feb. 26, 2019
-
Patent Title: System and apparatus for treating the lens of an eye Oct. 02, 2018
-
Patent Title: System and method of illumination of structures within an eye Aug. 21, 2018
-
Patent Title: Patient interface device for ophthalmic laser procedures May. 15, 2018
-
Patent Title: System and apparatus for delivering a laser beam to the lens of an eye Feb. 13, 2018
-
Patent Title: Second pass femtosecond laser for incomplete laser full or partial thickness corneal incisions Dec. 19, 2017
-
Patent Title: Laser system and method for correction of induced astigmatism May. 23, 2017
-
Patent Title: System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser Jan. 17, 2017
-
Patent Title: System and method for providing laser shot patterns to the lens of an eye Jun. 28, 2016
-
Patent Title: System and method of scan controlled illumination of structures within an eye Mar. 01, 2016
-
Patent Title: System and apparatus for treating the lens of an eye Nov. 10, 2015
Federal grants, loans, and purchases
Estimated quarterly amount awarded to LNSR from public contracts
Recent insights relating to LNSR
Recent picks made for LNSR stock on CNBC
ETFs with the largest estimated holdings in LNSR
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
---|
- Is $LNSR stock a Buy, Sell, or Hold?
- What is the price target for $LNSR stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
Shareholder
|
Shares Held
|
---|
- Who owns $LNSR stock?
- Who owns the most shares of $LNSR stock?
- What funds own $LNSR stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view LNSR Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
- Address Orlando, FL
- Market Cap 147.8 million
- Employees 140
- Industrial Classification Surgical & Medical Instruments & Apparatus